Belzutifan for treating tumours associated with von Hippel-Lindau disease

Supporting evidence

• Evaluation report

• Draft guidance consultation committee papers (PDF 16.31 MB)

  Published:

  16 October 2024

• Final draft guidance committee papers (PDF 2.97 MB)

  Published:

  16 October 2024